Details of the Drug Reposition

General Information of This Drug (ID: DM89NML)

• Drug Name: XL652/XL014 (DM89NML)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Metabolic disorder	DIS71G5H	5C50-5D2Z	Phase 1	[1]
Cardiovascular disease	DIS2IQDX	BA00-BE2Z	Phase 1	[1]

References

• [1] Clinical pipeline report, company report or official report of Exelixis (2011).